Clinical Trial Update: Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old

View source ↗

Summary

Completed clinical trial examining the impact of ApoE genotype on brain structure and function in adults aged 45-75 with Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | Conditions: Alzheimer's Disease | Status: COMPLETED